Parra J J, Alvarado M C, Monsalve P, Costa A L F, Montesinos G A, Parra P A
Department of Pediatric Dentistry, School of Pediatric Dentistry, University of Cuenca-Ecuador, Av. 12 de Abril y El Paraíso 3-52, Cuenca, Ecuador.
Cancer Institute, SOLCA-Cuenca, Cuenca, Ecuador.
Eur Arch Paediatr Dent. 2020 Feb;21(1):129-136. doi: 10.1007/s40368-019-00454-4. Epub 2019 Jun 18.
To evaluate changes in the oral health status of children under the age of 14 years with acute lymphoblastic leukaemia (ALL) attending a cancer centre before and after chemotherapy treatment.
A total of 32 children with ALL without distinction of gender were selected for study. The oral cavity of the patients was evaluated before the induction stage and 17 days later. Clinical evaluation of the submandibular, submental, and cervical lymph nodes was performed. Saliva samples were collected during the early morning hours. Bacterial plaque was assessed by using the Silness and Löe plaque index (SLPI) and gingiva status was evaluated with the gingival Löe and Silness index (GLSI). The WHO toxicity oral scale was used to record the degree of oral mucositis. The resulting data were analysed with McNemar's test, t test (for related samples), and Wilcoxon test.
There were statistically significant differences for palpable lymph nodes, paleness of oral mucosa, and ecchymoseis, respectively, P ≤ 0.000, P = 0.03, and P = 0.01, with these manifestations decreasing significantly after treatment. Incipient gingivitis had frequencies of 71.9% and 75% before and after treatment, respectively. The mean SLPI score declined significantly from 1.16 ± 0.52 (before treatment) to 0.56 ± 0.36 (after treatment) (P < 0.000); salivary flow increased significantly from 0.54 ± 0.34 to 1.22 ± 1.07 after chemotherapy treatment (P < 0.00). Oral mucositis was present in 24 children (75%) with a 1-2 severity level.
After chemotherapy treatment, there were changes in the oral conditions of children with ALL. Some manifestations decreased after treatment, whereas in others increased.
评估一家癌症中心14岁以下急性淋巴细胞白血病(ALL)患儿化疗前后口腔健康状况的变化。
共选取32例ALL患儿,不分性别进行研究。在诱导期前及17天后对患者口腔进行评估。对下颌下、颏下及颈部淋巴结进行临床评估。清晨采集唾液样本。采用希尔尼斯和勒氏菌斑指数(SLPI)评估菌斑,用牙龈勒氏和希尔尼斯指数(GLSI)评估牙龈状况。采用世界卫生组织口腔毒性量表记录口腔黏膜炎程度。所得数据用麦克尼马尔检验、t检验(用于相关样本)和威尔科克森检验进行分析。
可触及淋巴结、口腔黏膜苍白及瘀斑分别有统计学显著差异,P≤0.000、P = 0.03及P = 0.01,这些表现治疗后显著减轻。初期牙龈炎治疗前后发生率分别为71.9%和75%。SLPI平均得分从治疗前的1.16±0.52显著降至治疗后的0.56±0.36(P<0.000);化疗后唾液流量从0.54±0.34显著增加至1.22±1.07(P<0.00)。24例患儿(75%)出现口腔黏膜炎,严重程度为1 - 2级。
化疗后,ALL患儿口腔状况发生变化。部分表现治疗后减轻,而其他表现则有所增加。